Source: Annual Congress 2006 - Respiratory failure, pulmonary embolism and case reports
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. D. Tsonev, S. N. Nenkova, D. R. Dimitrov, D. N. Miteva, K. P. Kissiova (Varna, Bulgaria). Comparison of two regimens of oral anticoagulation in pulmonary embolism. Eur Respir J 2006; 28: Suppl. 50, 3694

Member's Comments

No comment yet.

Related content which might interest you: The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007 Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Duration of anticoagulation after isolated pulmonary embolism Source: Eur Respir J 2016; 47:1429-1435 Year: 2016 Initial dual oral combination therapy in pulmonary arterial hypertension Source: Eur Respir J 2016; 47:1727-1736 Year: 2016 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Recommended uses for indefinite secondary prophylaxis in patients with pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006 Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Thrombolytic therapy in massive pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006 Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli Source: ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020 Year: 2021